Skip to content

JMedInvest

Active Private limited companyfounded 2017active for 9 yearsVossemlaan 83, 1933 ZaventemKBO/BCE: BE 0671.921.671

Lifetime

9 annual accounts with figures on one time axis
peak of €116,684 in 2024
€82,305▼ 29.5%
peak of €65,943 in 2024
€25,179▼ 61.8%
peak of €199,004 in 2025
€199,004▲ 8.3%
€409,348▲ 105%
Board2 names since 2017
2 directors and 1 other
Owners
  
Documentsfilings and deeds
20-05-202672 days before the deadline
2025micro format
Gross margin from €116,684 to €82,305Result from €65,943 to €25,179Dividend €10,000Debts from €199,358 to €409,348Investments €242,746

Key points

from the 2025 annual accounts

Equity

€199,004 ▲ 8.3%

JMedInvest has made a profit in every financial year since 2018.

Turnover

≈ €180,000 estimated

The micro format states no turnover.

Debts

€409,348 ▲ 105%
Financial debts
+229,190
Suppliers
+3,816
The rest
-23,015

Debts rose by €209,990 in 2025.

Investments

€258,175 5.7 times depreciation
2021202220242025

Green is investment, beige is depreciation. Land and buildings stand 89.0% higher than in 2024.

Liquidity

3.25 was 1.82 in 2024

Short-term debts fell from €63,223 to €44,024.

Filings

8 annual accounts 9 filings since 2018
AprilJune31 JulyOctober20202025

The last five annual accounts were filed 29 to 72 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,638 companies had the same profile as JMedInvest has now. Each dot stands for 5 companies, two years later.

95.4%
were still trading
3.7%
stopped another way
0.5%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,638 companies, not a prediction for JMedInvest. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • 100%annual accounts 31-03-2018

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0671921671
New establishment in Woluwe-Saint-Lambert MHS Woluclinic, Bretagnestraat 20
resigns as director and manager reappointed as niet statutair arts bestuurder · General meeting of 26-10-2020 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares, €12,400 paid up · Founded by · appointed as manager · published on 02-03-2017 · Gazette deed
All 18 events

Comparable companies

same main activity, similar in size and age
Company
JMedInvest Zaventem €608,352 €82,305 32.7% -
Dr AM Vandersmissen - Kinder & Jeugdpsychiater Antwerp €542,503 €83,772 87.6% -
société médicale Docteur Fabian Warzée Fléron €623,177 €71,608 -9.4% -
37E Lubbeek €609,269 €75,650 17.0% -
HEYLEN GERALDINE Grez-Doiceau €524,002 €73,078 3.5% -
SOCIETE MEDICALE BIERLAIRE Le Roeulx €604,250 €84,186 84.2% 0
Dr. Chris Cambré Stabroek €697,747 €77,218 41.7% -

These companies have the same main activity as JMedInvest: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €524,000 and €698,000, founded between 2014 and 2018.

Official details

Source: KBO
Status
Active since 28-02-2017Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment units
2.262.133.1391933 Zaventem, since 28-02-2017
2.382.329.7971200 Woluwe-Saint-Lambert, since 01-01-2026
Financial year end
31 December
Peppol
Reachable since 06-01-2026
Company details

Annual accounts 2025

€608,352▲ 58.8%
Filing
Filed on 20-05-2026, 72 days before the end of the filing period
Financials

Insights on JMedInvest

JMedInvest files the micro format. That format states no turnover. The gross margin rose from €34,845 in 2018 to €82,305 in 2025.

The balance sheet grew most from 2024 to 2025 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about JMedInvest

What is the company number of JMedInvest?
The company number of JMedInvest is 0671.921.671. The VAT number is the same number with BE in front: BE 0671.921.671.
Where is JMedInvest based?
The registered office is at Vossemlaan 83, 1933 Zaventem.Company details
What does JMedInvest do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of JMedInvest?
JMedInvest is a private limited company (BV).
When was JMedInvest founded?
JMedInvest was founded on 28-02-2017.
Is JMedInvest still active?
Yes, JMedInvest is an active enterprise in the KBO register.
What is the turnover of JMedInvest?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €82,305 and 33 comparable companies (NACE 862). It probably lies between €140,000 and €230,000.Financials
Is JMedInvest profitable?
In financial year 2025, JMedInvest made a profit of €25,179.
Where can I find the annual accounts of JMedInvest?
JMedInvest filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of JMedInvest due?
JMedInvest must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.